Tricyclic heteroaromatic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2007319952 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Dong, Hong; Cox, Jason M.

Agent Spruson & Ferguson

Pub. Number AU-B-2007319952

PCT Pub. Number WO2008/060488

Priority 60/858,759 14.11.06 US

Filing date 9 November 2007

Wipo publication date 22 May 2008

Acceptance publication date 26 April 2012

International Classifications

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A01N 33/02 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds

A61K 31/13 (2006.01) - Amines, e.g. amantadine

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/060488 Priority application(s): WO2008/060488

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

26 April 2012 Application Accepted

  Published as AU-B-2007319952

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007319975-Photonic crystal sensors with integrated fluid containment structure

2007319951-Polymorphs of nicotinic intermediates